Financhill
Back

Structure Therapeutics Vs. Skye Bioscience Industry Stock Comparison

Sell
6

GPCR
Structure Therapeutics

Last Price:
$27.91
Seasonality Move:
-41.18%
Sell
12

SKYE
Skye Bioscience

Last Price:
$2.70
Seasonality Move:
59.61%
Sell
6
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $27.90. The Score for GPCR is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
12
Skye Bioscience (SKYE) is a Sell

Is Skye Bioscience a Buy, Sell or Hold?

  • The current Skye Bioscience [SKYE] share price is $2.72. The Score for SKYE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • SKYE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $27.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

SKYE Stock Price Chart

What is Skye Bioscience's stock price today?

  • The Skye Bioscience share price today is $2.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKYE is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.72 Sell
Relative Strength Index (14 RSI): 35.5 Sell
Chaikin Money Flow: -1322544 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.51 - 34.27) Sell
Bollinger Bands (100): (33.57 - 40.75) Sell

SKYE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 25.62 Sell
Chaikin Money Flow: -349443 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.3 - 4.42) Sell
Bollinger Bands (100): (3.78 - 5.7) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.68 Sell
20-day SMA: 32.41 Sell
50-day SMA: 35.41 Sell
200-day SMA: 38.71 Sell
8-day EMA: 30.31 Sell
20-day EMA: 32.11 Sell
50-day EMA: 34.63 Sell
200-day EMA: 37.98 Sell

SKYE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.18 Sell
20-day SMA: 3.71 Sell
50-day SMA: 4.43 Sell
200-day SMA: 7.79 Sell
8-day EMA: 3.15 Sell
20-day EMA: 3.63 Sell
50-day EMA: 4.24 Sell
200-day EMA: 5.91 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.08 per share.

Skye Bioscience Earnings Growth & SKYE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.55 per share, and a decrease next year of $0.26 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Skye Bioscience Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):